Teclistamab’s place in the myeloma treatment landscape
Amrita Krishnan, MD, City of Hope, Duarte, CA, shares her insights into advancements in drugs used to treat multiple myeloma. Dr Krishnan draws focus on how treatment options are changing, using bispecific antibodies targeting novel targets such as GPRC5D as an example. This interview took place at the 63rd ASH Annual Meeting and Exposition, Atlanta, 2021.
